To function optimally, human blood natural killer (NK) cells need to communicate with other immune cells. Previously, it has been shown that NK cells communicate with 6-sulfo LacNAc dendritic cells (slanDCs), which are able to stimulate NK cells in vitro. In this study, we investigated how slanDCs regulate the level of NK cell activation. The secretion of interleukin (IL)-1β by slanDCs during coculture with NK cells increased as a result of signaling via intercellular adhesion molecule-1 on slanDCs following its interaction with lymphocyte functionassociated antigen-1 on NK cells. IL-1β induced the expression of Fas receptor (CD95) on NK cells. The binding of Fas ligand (CD178) to CD95 induced the apoptosis of activated NK cells. Moreover, IL-1β also induced increased cyclooxygenase-2 expression in slanDCs, which in turn enabled the cells to secrete prostaglandin (PG)-E2. Consequently, PGE2 acted as a suppressing agent, tuning down the activation level of NK cells. In summary, IL-1β limits the level of NK cell activation by inducing apoptosis and suppression as a homeostatic regulatory function.
INTRODUCTION
Efficient immune responses require coordinated reciprocity between different immune cells. It has been shown that natural killer (NK) cells and dendritic cells (DCs) are two types of innate immune cells that communicate to establish an optimal immune response during infection or tumor infiltration. [1] [2] [3] [4] NK cells are a group of innate lymphocytes defined by the surface expression of CD56 and lack of CD3. [5] [6] [7] They exert strong cytotoxic effects against tumor cells or virus-infected cells without a need for prior antigen sensitization 8, 9 and produce high amounts of cytokines and chemokines to modulate immune responses. 6, 8, 9 However, the nature of NK cell functions depends on their interactions with other immune cells, such as slanDCs. 8, 10 SlanDCs represent a major subpopulation of proinflammatory human blood DCs and differ from other DC subsets due to their selective expression of 6-sulfo LacNAc1 (a carbohydrate modification of P-selectin glycoprotein ligand-1). 10, 11 Functionally, it has been reported that slanDCs efficiently improve the immunomodulatory and cytotoxic potential of NK cells. 3, 12, 13 A previous study has demonstrated that slanDCs utilize membrane-bound tumor necrosis factor (mTNF)-α to activate NK cells. 13 The role of interleukin (IL)-12 released by slanDCs for NK cell activation has also been reported. 3, 13 In addition to IL-12 and TNF-α, slanDCs also produce proinflammatory cytokines such as IL-1β upon stimulation with Toll-like receptor (TLR) 4, TLR7/8 or CD40 ligand. 14, 15 A study has reported significantly increased production of IL-1β by slanDCs after coculture with NK cells, for which direct cell-cell contact was required. 13 However, the detailed mechanism by which NK cells modulate IL-1β production by slanDCs and the typical role of this cytokine during NKslanDC crosstalk remained unexplored. Therefore, we investigated the potential role of intercellular adhesion molecule (ICAM)-1 signaling in the increased IL-1β production by slanDCs following its interaction with lymphocyte functionassociated antigen (LFA)-1 (CD11a and CD18) on NK cells. ICAM-1 is expressed in different cell types and is readily upregulated by different inflammatory stimulants. 16, 17 It binds to its principal receptor, LFA-1, which is expressed by different immune cells such as lymphocytes, macrophages and neutrophils. 18, 19 Although ICAM-1 is well known as an adhesion molecule, its signaling in lymphocytes can also result in cytokine release. 17, 20 IL-1β is a member of the IL-1 proinflammatory cytokine family that is synthesized in its mature, bioactive form from proIL-1β with the help of IL-1 converting enzyme. 21, 22 IL-1β is released by different innate immunoregulatory cell types such as monocytes, DCs and macrophages. [21] [22] [23] Through binding to its receptor (IL-1R1), IL-1β has an important role in host defense against infection. [22] [23] [24] Therefore, our study aimed to investigate whether the increased production of IL-1β during coculture controls the apoptosis of activated NK cells. Moreover, we also studied how IL-1β tunes down the level of activation of NK cells by inducing the expression of cyclooxygenase (COX)-2 in slanDCs. COX-2 is well known as the ratelimiting enzyme for the production of prostaglandin (PG)-E2. 25 PGE2 has been reported as a suppressive factor for immune cells. [26] [27] [28] 
MATERIALS AND METHODS

Samples
Following the provision of written informed consent, blood samples were obtained from healthy individuals visiting the Institute of Transfusion Medicine at Hannover Medical School. The study was approved by the local ethical committee of Hannover Medical School (MHH Ethics Committee, No. 830).
Cells and culture conditions
Peripheral blood mononuclear cells (PBMCs) were separated using Ficoll density gradient centrifugation. Isolation of NK cells and slanDCs was performed by FACS as previously described. 13 Freshly sorted slanDCs and NK cells were cultured separately (at 1 × 10 5 cells/100 μl) using RPMI 1640 media (Biochrom; Berlin, Germany) supplemented with 10% FCS, 1 mM L-glutamine, 50 U/ml penicillin, 0.5 mM sodium pyruvate and 50 μg/ml streptomycin. Moreover, freshly isolated slanDCs were cocultured with sorted autologous NK cells at a ratio of 1:5. PBMCs were cultured at a concentration of 3 × 10 6 cells/ml. The cells were cultured in 24-well suspension culture plates (Greiner; Frickenhausen, Germany) for 16 h and 25 ng/ml lipopolysaccharide (LPS; Sigma; Seelze, Germany) was used to stimulate the slanDCs.
Flow cytometric analysis
Analyses of surface and intracellular molecules of NK cells and slanDCs were performed using the following monoclonal antibodies: anti-CD3-BD Horizon V500, anti-CD45-PerCp, anti-CD107a-FITC, anti-bcl2-FITC, anti-caspase-3-PE, phosphorylated c-Jun N-terminal kinase (JNK)-PE, antiphosphorylated NF-kB-p65-PE (all from BD Biosciences, Heidelberg, Germany), anti-CD3-APC, anti-CD19-APCCy7/BV510, anti-CD54-FITC, anti-CD56-BV510/PE-Cy7, anti-CD95-FITC, anti-CD178-PE, anti-HLA-DR-BV421, anti-IFN-γ-PE (all from Biolegend; San Diego, CA, USA), anti-CD69-PE (Invitrogen, Darmstadt, Germany), anti-slan (M-DC8)-APC/PE (both from Miltenyi Biotec, Bergisch Gladbach, Germany), anti-COX-2-FITC (Cayman Chemical; Ann Arbor, MI, USA) and anti-IL-1β-FITC/PerCp (R&D Systems, Wiesbaden, Germany). The negative controls were included as fluorochrome-conjugated isotype-matched antibodies from the respective companies. The samples were measured using a FACSCanto II flow cytometer.
Detection of cell surface molecules
To evaluate the influence of slanDCs on the expression of CD11a, CD18, CD69, CD95 and CD178 on NK cells, we cocultured NK cells with slanDCs in the presence of LPS. Furthermore, coculture was performed in the presence of 10 μg/ml anti-CD11a (Biolegend) or anti-IL-1β (eBioscience; San Diego, CA, USA) blocking antibodies. NK cells were also incubated without slanDCs in the presence or absence of LPS or 2 ng/ml rhIL-1β. To evaluate ICAM-1 (CD54) and CD178 surface expression on slanDCs, sorted slanDCs or PBMCs were cultured in the presence or absence of LPS. The expression of surface molecules on NK cells and slanDCs was analyzed by flow cytometry.
Detection of intracellular proteins NK cells were cocultured with slanDCs and LPS in the presence or absence of COX inhibitors (20 μM indomethacin or 5 μM NS398 (both from Cayman Chemical)), 10 μg/ml anti-IL-1β or 0.1 μg/ml anti-CD95 (ZB4) blocking antibody (Biolegend). NK cells and slanDCs were also incubated separately in the presence or absence of LPS, anti-IL-1β, anti-CD54 or anti-CD95 blocking antibodies. The NK cells were negatively separated from slanDCs in MS columns using anti-slan (M-DC8) microbeads (Miltenyi Biotec) according to the manufacturer's protocol. The NK cells (purity 498%) were incubated with 2 μg/ml brefeldin A (Sigma) for 3 h and were then analyzed for their intracellular expression of bcl2, caspase-3 and IFN-γ by flow cytometry as previously described. 7 To measure phosphorylated JNK and phosphorylated NF-κB-p65 levels in slanDCs during coculture, slanDCs were first stimulated with LPS for 16 h to induce the upregulation of CD54 expression. Then, the slanDCs were coincubated with NK cells for 20 min followed by intracellular staining as previously described 13 to analyze phosphorylated JNK and phosphorylated NF-κB-p65. The intracellular IL-1β and COX-2 levels in slanDCs were also analyzed as previously described. 13, 27 To assess late apoptosis (Annexin-V + /7AAD + ) and early apoptosis (Annexin-V + /7AAD − ) in NK cells and slanDCs, an Annexin-V/7AAD kit (Beckman Coulter, Krefeld, Germany) was used as previously described. 13 To measure IL-1β and GM-CSF in culture supernatants, a cytometric bead array flex set (BD Biosciences) was used according to the company's instructions; FCAP array software V.3 was used for data analysis. PGE2 in the culture supernatants was measured using a commercially available PGE2 ELISA kit as previously described. 29 IL-1β controls level of NK cell activation by DCs DM Tufa et al NK cell degranulation assay NK cells were cocultured with slanDCs and LPS in the presence or absence of COX inhibitors (20 μM Indomethacin or 5 μM NS398). Subsequently, the NK cells were negatively separated from slanDCs as previously described 13 with an NK cell purity of 498%, and NK cell degranulation stimulated by K562 target cells was analyzed using a CD107a assay. The NK cells and K562 cells were cocultured at an E:T ratio of 10:1 in the presence of anti-CD107a-FITC, and Monensin (BD Biosciences) was added 1 h later at a final concentration of 6 μg/ml. Following the 4 h total coincubation, the cells were stained for surface markers, washed and analyzed for the surface expression of CD107a by flow cytometry.
Statistical analysis
Paired two-tailed t-tests (to compare two groups) or one-way analysis of variance (ANOVA) followed by Bonferroni posttests (to compare three or more groups) were applied to evaluate the statistical significance of the observed differences. GraphPad Prism software V5 (GraphPad, Inc., La Jolla, CA, USA) was used for statistical analysis.
RESULTS
NK cells enhance IL-1β secretion by slanDCs
Upon stimulation, slanDCs produce several proinflammatory cytokines such as IL-1β, IL-12 and TNF-α. 11, 13, 15 In a previous study, direct cell-cell contact with NK cells enhanced IL-1β production by slanDCs. 13 However, the mechanism by which NK cells enhance IL-1β production by slanDCs remained unknown. In this study, our blocking experiment using an anti-CD11a antibody revealed that the binding of LFA-1 (CD11a and CD18) on NK cells to ICAM-1 (CD54) on slanDCs induced signaling that activated NF-κB in slanDCs (Figures 1a and b) . JNK was also activated in slanDCs by ICAM-1 signaling, as shown in the LFA-1 blocking experiment (Figures 1c and d) . It is well known that the activation of the NF-κB and JNK pathways increases the release of various proinflammatory cytokines such as IL-1β. 30, 31 It was therefore not unexpected that blocking ICAM-1 signaling in the coculture by using an anti-CD11a blocking antibody abrogated the enhanced secretion of IL-1β by slanDCs (Figure 1e) . Alternatively, intracellular staining revealed that the use of an anti-CD54 blocking antibody also abrogated the enhanced secretion of IL-1β by slanDCs in the coculture (Figure 1f ). Intracellular staining detected no significant amounts of IL-1β in NK cells cocultured with slanDCs (data not shown). Addition of an anti-CD11a blocking antibody to the slanDC culture did not affect the baseline production of IL-1β by slanDCs (data not shown). In contrast, the presence of the anti-CD11a blocking antibody in the coculture resulted in an increase in apoptotic NK cells and apoptotic slanDCs (Figures 1g and h ). To induce ICAM-1 signaling, NK cells upregulated LFA-1 components after coculture with slanDCs in the presence of LPS (Figures 2a-d) . Similarly, slanDCs upregulated CD54 in the coculture in the presence of LPS (Figure 2e) . Stimulation of PBMCs with LPS also resulted in the significant upregulation of CD54 on slanDCs (Figure 2f ).
IL-1β controls the apoptosis of NK cells by inducing the expression of CD95
A previous study reported that slanDCs activate NK cells in vitro. 13 However, it was not known whether those activated cells also undergo apoptosis as a homeostatic response. Here we measured a significantly higher proportion of early and late apoptotic NK cells after coculture with slanDCs in the presence of LPS (Figures 3a and b) . NK cells expressed more intracellular active caspase-3 (Figures 3c and d) , but less of the antiapoptotic molecule bcl-2, after coculture with slanDCs (Figures 3e and f) . Our blocking experiments indicated that binding of NK cell CD95 to its ligand CD178 has a role in inducing NK cell apoptosis (Figures 4a and b) . Both Fas (CD95) expression and FasL (CD178) expression were upregulated on NK cells upon coculture with slanDCs in the presence of LPS (Figures 4c-e) . LPS stimulation was sufficient for slanDCs to upregulate their surface CD178 expression (Figure 4f ). Although we do not yet know which molecule is responsible for the upregulation of CD178, IL-1β released during coculture increased the surface expression of CD95 on NK cells (Figures 4g and h) . Therefore, blocking of IL-1β also significantly abrogated the occurrence of apoptosis in NK cells (Figures 4i and j) . Although the addition of rhIL-1β to the NK cell culture medium upregulated CD95 in NK cells (as shown above in Figure 4g ), it did not significantly enhance the level of apoptotic cells (data not shown).
IL-1β limits the level of NK cell stimulation by inducing the release of PGE-2
The function of other molecules, such as mTNF-α and IL-12, has been reported during slanDC-mediated stimulation of NK cell functions such as cytotoxicity and cytokine production. 3, 13 However, the regulatory role of IL-1β during the stimulation of NK cells by slanDCs in a coculture has not been addressed. Here we report significantly higher intracellular COX-2 expression in slanDCs cocultured with NK cells (Figure 5a ). However, COX-2 expression in slanDCs was significantly reduced in the presence of an anti-IL-1β blocking antibody in coculture (Figure 5b ). COX-2 is a rate-limiting enzyme that is required for PGE2 production. 25 Our ELISA results showed remarkable PGE2 production by LPS-stimulated slanDCs. However, there was no significant difference between the concentration of PGE2 in LPS-stimulated slanDC cultures and LPS-stimulated slanDC-NK cell cocultures (Figure 5c ). NK cells express the PGE2 degrading enzyme hydroxyprostaglandin dehydrogenase (HPGD; data not shown), and PGE2 has been reported as a suppressive factor for immune cells. 26, 27 Consistent with this, the inhibition of PGE2 by COX inhibitors added to the coculture resulted in a further significant increase in NK cell activation (Figure 5d ). Furthermore, PGE2 inhibition in the coculture also resulted in significantly increased GM-CSF release (Figure 5e ), intracellular IFN-γ (Figure 5f ) and CD107a degranulation (Figures 5g and h ) in NK cells.
A previous study reported that slanDCs do not produce GM-CSF and IFN-γ but that these are produced by NK cells. 13 enhance the release of IL-1β by slanDCs via a mechanism that requires cell-cell contact. 13 Therefore, we were interested in studying the role of increased IL-1β secretion in the coculture. IL-1β is a member of the IL-1 proinflammatory cytokine family that is released primarily by activated monocytes in response to a wide variety of infectious stimuli. Through binding to its receptor (IL-1R1), IL-1β has an important role in host defense by inducing inflammation during infections. 21, 23 In our study, blocking experiments revealed that NK cells used LFA-1 to bind to ICAM-1 on slanDCs, thereby enhancing the release of IL-1β by slanDCs. Addition of an anti-CD11a blocking antibody to the coculture completely abrogated the release of IL-1β to the culture supernatant. CD54 blocking in IL-1β controls level of NK cell activation by DCs DM Tufa et al the coculture also significantly reduced the proportion of slanDCs expressing IL-1β. Apart from its blocking activity, the anti-CD11a blocking antibody also initiated apoptosis in both NK cells and slanDCs during coculture. Therefore, the complete inhibition of IL-1β release in the presence of antiCD11a blocking antibody observed in the coculture might be due to the combined effect of blocking and apoptosis. Blocking CD11a in the slanDC culture did not affect the proportion of slanDCs producing IL-1β, indicating that ICAM-1 transsignaling via LFA-1 on NK cells is essential. LFA-1 and ICAM-1 were upregulated in NK cells and slanDCs, respectively, during coculture. ICAM-1 (CD54) is expressed in various cell types, is readily upregulated by different inflammatory stimuli 16, 17 and is well known as an adhesion molecule. 18, 20 In lymphocytes, ICAM-1 stimulation can also lead to signaling that results in transcription factor phosphorylation and cytokine release. 19, 20 The activation of NF-κB and JNK in slanDCs through ICAM-1 signaling shown in our study is additional evidence of the role of ICAM-1 in downstream slanDC functions. Although they enhanced the release of IL-1β from slanDCs, NK cells themselves were not able to produce significant amounts of IL-1β in the coculture.
DISCUSSION
As the main objective of this investigation, we studied the role of elevated IL-1β under in vitro coculture conditions. First, IL-1β induced the expression of Fas receptor (CD95) in NK cells during coculture with slanDCs. Thus far, unknown factors increased the expression of Fas ligand (CD178) on both NK cells and slanDCs in the coculture. CD95 is a member of the TNF receptor family and is a type I membrane protein expressed by different cell types. The binding of CD178 to CD95 activates the caspase cascade, resulting in apoptosis and cell death. 38 Therefore, we observed a higher proportion of NK cells undergoing apoptosis in the presence of elevated IL-1β during in vitro coculture. During 16 h of coculture, the overall proportion of NK cells undergoing apoptosis varied between donors. However, for all donors, the proportion of apoptotic , c and f) The data are shown as the mean ± s.d. and are representative of four to five independent experiments. *Po0.05, **Po0.01 and ***Po0.001, paired two-tailed t-tests (a, c) or one-way ANOVA followed by Bonferroni posttests (f).
IL-1β controls level of NK cell activation by DCs DM Tufa et al NK cells doubled in coculture with slanDCs in comparison to NK cells cultured alone. In the absence of LPS, slanDCs did not release significant amounts of IL-1β into the coculture supernatant. Concomitantly, CD95 was not upregulated on NK cells, meaning that no significant apoptosis was induced. However, the upregulation of CD95 in NK cells by rhIL-1β was not sufficient to enhance apoptosis. This might indicate the requirement for FasL on slanDCs to induce apoptosis in activated NK cells during coculture. The observation that IL-1β regulates the apoptosis of NK cells by dictating the expression of CD95 on NK cells is a new finding. Moreover, the increased IL-1β in our in vitro coculture served as a regulator of NK cell activation. IL-1β tuned down NK cell activation by modulating COX-2 expression in slanDCs. In the presence of elevated IL-1β, slanDCs expressed higher levels of COX-2. COX-2 has been described as the rate-limiting enzyme for PGE2 production. 25 LPS-stimulated slanDCs produced high levels of PGE2. Although the expression of COX-2 was significantly upregulated in slanDCs cocultured with NK cells compared with slanDCs cultured alone, there was no significant difference between the PGE2 levels in slanDC cultures and slanDC-NK cell cocultures. This might be due to the degradation of PGE2 by NK cell HPGD, a PGE2 degrading enzyme. PGE2 is well known for its suppressive activity on immune cells such as NK cells. 26, 27 Previous reports have shown that slanDCs are capable of increasing the activation and function of NK cells in cocultures. 3, 12, 13 In the current study, the production of PGE2 was reduced by the application of COX inhibitors. For PGE2 inhibition, the nonspecific COX inhibitor indomethacin or the COX-2-specific inhibitor NS398 was used. NS398 treatment was used to study the specific effect of COX-2 in the coculture. COX inhibition further enhanced the activation, cytotoxicity and cytokine production of NK cells, and indeed, specific blocking of COX-2 was sufficient to increase NK cell functions. However, the proportion of apoptotic NK cells also increased with stimulation. This suggests that in the absence of PGE2 secretion, IL-1β can still control the level of activation via apoptosis induction in activated NK cells. release of this cytokine in the body. Therefore, this study suggests the importance of IL-1β during the in vitro stimulation of NK cells, which might also be relevant in vivo.
